PlainRecalls
FDA Devices Moderate Class II Terminated

G-6-PDH Normal Control (G-6-PDH CONTROL N), Catalogue Number PD2618 Product Usage: This product is intended for in vitro diagnostic use, in the quality control of Glucose-6-Phosphate Dehydrogenase in erythrocytes

Reported: May 8, 2019 Initiated: April 3, 2019 #Z-1255-2019

Product Description

G-6-PDH Normal Control (G-6-PDH CONTROL N), Catalogue Number PD2618 Product Usage: This product is intended for in vitro diagnostic use, in the quality control of Glucose-6-Phosphate Dehydrogenase in erythrocytes

Reason for Recall

The target values and ranges in these lots are incorrect.

Details

Recalling Firm
Randox Laboratories Ltd.
Units Affected
10 kits
Distribution
The products were distributed to the following US states: IL, OH, NC, PA, WI, WV and Puerto Rico.
Location
Crumlin (North), N/A

Frequently Asked Questions

What product was recalled?
G-6-PDH Normal Control (G-6-PDH CONTROL N), Catalogue Number PD2618 Product Usage: This product is intended for in vitro diagnostic use, in the quality control of Glucose-6-Phosphate Dehydrogenase in erythrocytes. Recalled by Randox Laboratories Ltd.. Units affected: 10 kits.
Why was this product recalled?
The target values and ranges in these lots are incorrect.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 8, 2019. Severity: Moderate. Recall number: Z-1255-2019.